| Name | (2S)-4-[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid |
|---|---|
| Synonyms |
Fmoc-Asn(GlcNAc(Ac)-β-D)-OH
2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-D-glucopyranosyl-Fmoc-aspagine FMoc-Asn(GlcNAc(Ac)3-b-D)-OH Fmoc-Asn(β-D-GlcNAc(Ac)3-OH Fmoc-L-Asn(GlcNAc(Ac)3-beta)-OH Na-Fmoc-Ng-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-b-glucopyranosyl)-L-aspagine (HPLC) FMoc-Asn(β-D-GlcNAc(Ac)3)-OH MFCD00237079 Fmoc-L-Asn(2-D-GlcNAc(Ac)3-OH N-(9-Fluorenylmethoxycbonyl)-N'-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-BETA-D-glucopyranosyl)-L-aspagine FMOC-ASN(AC3ACNH-BETA-GLC)-OH //BP L-Aspagine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl] N-ALPHA-(9-FLUORENYLMETHYLOXYCBONYL)-N-BETA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-BETA-D-GLUCOPYRANOSYL)-L-ASPAGINE Fmoc-Asn(GlcNAc(Ac)-β-D)-OH N-ALPHA-FMOC-N-BETA-(3,4,6-TRI-O-ACETYL-2-(ACETYLAMINO)-DEOXY-2-BETA-GLUCOPYRANOSYL)-L-ASPAGINE Fmoc-ASN(Ac3AcNH-β-GLC)-OH N-(9-Fluorenylmethyloxycbonyl)-N'-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-beta-D-glucopyranosyl)-L-aspagine FMOC-ASN(GLCNAC(AC)3-B)-OH (2S)-4-[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]amino]-2-(9H-fluoren-9-ylmethoxycbonylamino)-4-oxobutanoicaci FMOC-ASPAGINE(GLCNAC(AC)3-BETA-D)-OH N-ALPHA-(9-FLUORENYLMETHYLOXYCBONYL)-N-GAMMA-(2-ACETAMIDO-2DEOXY-3,4,6-TRI-O-ACETYL-BETA-D-GALACTOPYRANOSYL)-L-ASPAGIN Fmoc-Asn(GlcNAc(Ac)3-β-D)-OH fmoc-asn(a Fmoc-L-Asn(GlcNAc4)-OH (2S)-4-[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]amino]-2-(9H-fluoren-9-ylmethoxycbonylamino)-4-oxobutanoic acid Fmoc-Asn(b-D-GlcNAc(Ac)3)-OH FMOC-ASN(GLCNAC(AC)3-BETA-D)-OH (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(((2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)amino)-4-oxobutanoic acid N-ALPHA-FMOC-N-GAMMA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-BETA-D-GLUCOPYRANOSYL)-L-ASPAGINE Fmoc-Asn(Ac3GlcNAcβ)-OH Fmoc-Asn(β-D- GlcNHAc(Ac)3)-OH Fmoc-L-Asn(GlcNAc(Ac)3-b)-OH (S)-2-(((9H-fluoren-9-yl)methyl9H-fluoren-9-yl)methoxy)cbonylamino)-4-((2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-ylamino)-4-oxobutanoic acid N-FMOC-N-ALPHA-(2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSYL)-L-ASPAGINE 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranosyl-Fmoc-aspagine N-a-FMoc-N-g-(2-acetaMido-2-deoxy-3,4,6-tri-O-acetyl-b-D-glucopyranosyl)-L-aspagine (N-ALPHA-FMOC-N-GAMMA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-BETA-GLUCOPYRANOSYL)-L-ASPAGINE) Fmoc-L-Asn(β-D-GlcNAc(Ac)3)-OH FMOC-L-ASN(GLCNAC)-OH 2N-Fmoc-92-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranosyl)-L-aspagine 3-{[4,5-BIS(ACETYLOXY)-6-[(ACETYLOXY)METHYL]-3-ACETAMIDOOXAN-2-YL]CBAMOYL}-2-{[(9H-FLUOREN-9-YLMET Fmoc-L-Asn((Ac)3-beta-D-GlcNAc)-OH >= (HPLC) Fmoc-Asn(AcAcNH--Glc)-OH Fmoc-L-Asn(β-D-GlcNAc(Ac)3-OH N-ALPHA-(9-FLUORENYLMETHOXYCBONYL)-N-GAMMA-(2-ACETAMIDE-2-DEOXY-3,4,6-TRI-O-ACETYL-BETA-D-GLUCOPYRANOSYL)-L-ASPAGINE GLCNAC L-ASPAGINE FMOC-ASN(AC3ACNH-BETA-GLC)-OH 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranosyl-Fmoc-aspagine N-alpha-Fmoc-N-gamma-(2-acetamido-2-deoxy-3,4,6-tr Fmoc-L-Asn((Ac)3-β-D-GlcNAc)-OH Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH N-alpha-(9-Fluorenylmethyloxycbonyl)-N-gamma-(2-acetamido-2deoxy-3,4,6-tri-O-acetyl-beta-D-glucopyranosyl)-L-aspagin |
| Description | Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH (Fmoc-Asn(Ac3AcNH-beta-Glc)-OH) can be used in the synthesis of silicon-fluoride acceptor (SiFA) derivatized octreotate derivatives. SiFA-octreotate analogues, as tumor imaging agents, are useful tool for the research of positron emission tomography (PET)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C33H37N3O13 |
|---|---|
| Molecular Weight | 683.65900 |
| Exact Mass | 683.23300 |
| PSA | 221.96000 |
| LogP | 2.31340 |
| Storage condition | -15°C |
| RIDADR | NONH for all modes of transport |
|---|
| Precursor 5 | |
|---|---|
| DownStream 0 | |